Editorial: the acid test-can bile acids predict recurrence of Clostridioides difficile infection? Authors' reply

被引：0
|
作者：
Mullish, Benjamin H. [1 ,2 ,3 ]
Martinez-Gili, Laura [1 ,4 ]
Allegretti, Jessica R. [5 ,6 ,7 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, Div Digest Dis, St Marys Hosp Campus, London, England
[2] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Gastroenterol & Hepatol, London, England
[3] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Hepatol, London, England
[4] Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Div Syst Med,Sect Bioinformat, London, England
[5] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[6] Harvard Med Sch, Boston, MA USA
[7] Brigham & Womens Hosp, Hepatol & Endoscopy, 850 Boylston St,Suite 201, Chestnut Hill, MA 02467 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 01期
关键词：
D O I：
10.1111/apt.17303
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：169 / 170
页数：2
相关论文
共 34 条
  • [31] Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients
    Miller, Ryan
    Morillas, J. A.
    Brizendine, Kyle D.
    Fraser, Thomas G.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (03)
  • [32] Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention
    McCormick, Winston L.
    Jackson, Gail
    Andrea, Sarah B.
    Whitehead, Valerie
    Chargualaf, Tiffany L.
    Touzard-Romo, Francine
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024, 45 (01) : 106 - 109
  • [33] Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio Reply
    Vaughn, Byron P.
    Kao, Dina
    Kelly, Colleen R.
    GASTROENTEROLOGY, 2024, 167 (03) : 628 - 629
  • [34] Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply
    Bertani, Lorenzo
    Pugliese, Daniela
    Trico, Domenico
    Costa, Francesco
    Blandizzi, Corrado
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (02) : 348 - 349
1234